ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Policlinico Universitario Agostino Gemelli at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Policlinico Universitario Agostino Gemelli takes part in 22 sessions at ESMO 2026 in Madrid. Its program spans several cancer types, with particular attention to gynaecological cancers and treatment decisions. Topics include ovarian and endometrial cancer therapies, including results from trials of treatments for recurrent ovarian cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Research and teaching hospital of the Catholic University of the Sacred Heart in Rome, Italy.
Satellite
Fri Oct 23
09:45–11:15
MSD - Emerging Evidence and Treatment Integration in Ovarian and Endometrial Cancer
with European Institute of Oncology (IEO)
Gynaecological cancersBiomarkers & precision oncology
Satellite
Fri Oct 23
10:53–11:08
Emerging targeted approaches in endometrial cancer and future clinical integration
MSD - Emerging Evidence and Treatment Integration in Ovarian and Endometrial Cancer
Gynaecological cancersBiomarkers & precision oncology
Satellite
Fri Oct 23
11:13–11:15
Closing
MSD - Emerging Evidence and Treatment Integration in Ovarian and Endometrial Cancer
Gynaecological cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Clinical and molecular predictors of outcome in resected and metastatic GIST: A real-world cohort
ePoster session 20
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
EC_ItaLynch: Mainstreaming genetic testing for Lynch syndrome in endometrial cancer
ePoster session 7
Gynaecological cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Abstract
Fri Oct 23
16:42–16:47
Chair
Sat Oct 24
08:30–10:00
Rapid oral 2: Gynaecological cancers
with Evangelische Kliniken Essen-Mitte, University Hospitals Leuven
Gynaecological cancers
Abstract
Sat Oct 24
09:02–09:14
Invited Discussant LBA41 and 1248RO
Rapid oral 2: Gynaecological cancers
Gynaecological cancers
Chair
Sat Oct 24
14:45–16:15
Proffered paper: AI and digital health
with German Cancer Research Center (DKFZ)
Abstract
Sat Oct 24
15:49–16:01
Invited Discussant 170O and LBA20
Proffered paper: AI and digital health
Satellite
Sun Oct 25
13:05–13:15
Building Bridges in the Management of CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:15–13:35
Resectable or Not: Navigating the Gray Zones in Advanced CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:35–13:50
Defining High-risk CSCC: Identifying Patients Who Need More
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:50–14:20
Timing and Selection of Systemic Therapy in Resectable CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
14:20–14:30
Audience Q&A
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
18:30–20:00
Satellite
Sun Oct 25
18:30–18:40
Opening Keynote - The evolution of precision oncology: Science vs the implementation gap
MSD - Is the precision medicine ecosystem ready? Overcoming diagnostic barriers in oncology
Biomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
A proteo-energetic transcriptomic signature and mitochondrial-associated genes identify poor-prognosis in ovarian cancer
Monday Poster Display session 1
Gynaecological cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Letrozole in heavily pretreated recurrent ovarian cancer: The randomized phase III multicentre MITO 32 study
Monday Poster Display session 1
Gynaecological cancers
Poster
Mon Oct 26
12:00–12:45
Niraparib first-line maintenance in optimally debulked ovarian cancer patients: Genomic alterations and survival by molecular status
Monday Poster Display session 1
Gynaecological cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Second primary malignancies in patients with GIST: Clinical and molecular correlates in a real-world cohort
Monday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Policlinico Universitario Agostino Gemelli

Tell us what you sell and we’ll find the people at Policlinico Universitario Agostino Gemelli most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction